Global industry alliance announces new partnerships

IFPW and Gavi strengthen immunization supply chains in developing countries

At the World Economic Forum, Davos, Switzerland

Client

The International Federation of Pharmaceutical Wholesalers (IFPW), the world’s leading pharmaceutical wholesale industry association, represents over 40 companies across 6 continents, including several Fortune 500 companies. IFPW member companies comprise 40% of the global pharmaceutical distribution market.

Opportunity

Position IFPW as a major player in improving global health and enable IFPW and Gavi, the Vaccine Alliance, to strengthen immunization supply chains in developing countries.The annual World Economic Forum (WEF) meeting in Davos, Switzerland engages the world’s top political and business leaders in collaborative action. Focused on shaping global, regional and industry agendas, its mission is to improve the state of the world. The WEF’s 2015 theme was “New Global Context” with topics highlighting profound technological, political, economic and social changes, including health, with a focus on economic integration and international partnerships.

Impact

  • Developed and delivered IFPW’s announcement of a pioneering three-year multi-million dollar partnership with Gavi that highlighted the critical role of the private sector’s unique capabilities to enhance supply chains in global health
  • Defined how the new partnership could advance access to vaccines for children in over 70 developing countries where Gavi supports immunization programs
  • Bolstered IFPW’s position as a new business partner in global health

 

Additional Resources:

IFPW and Gavi Press Release

About IFPW and Global Development Collaboration

Highlights from WEF 2015

The IFPW’s new partnership with Gavi is an exciting milestone for the organization, as it looks to advance its social responsibility agenda on a global scale. We look forward to sharing our industry’s knowledge, expertise and resources with Gavi, as well as its partners, to strengthen medical supply chains in developing countries and to improve the ability and accessibility to vaccines for the children who need them.’
Ornella Barra, Chairwoman, IFPW